MP

Michel Perricaudet

AS Aventis Pharma S.A.: 7 patents #2 of 170Top 2%
CN CNRS: 2 patents #6 of 203Top 3%
IP Institut Pasteur: 1 patents #31 of 97Top 35%
📍 Rambouillet, FR: #2 of 19 inventorsTop 15%
Overall (2002): #2,089 of 266,432Top 1%
9
Patents 2002

Issued Patents 2002

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
6489142 Methods and compositions for producing viral particles Christophe Torrent, Patrice Yeh, David Klatzmann, Jean-Loup Salzmann 2002-12-03
6482617 Viable contaminant particle free adenoviruses, their preparation and use Patrice Yeh, Cecile Orsini 2002-11-19
6475755 Adenoviral vectors for mutants of human interleukin 6 (hIL-6) with hIL-6 antagonist activity, pharmaceutical compositions therewith and their uses Gennaro Ciliberto, Isabella Saggio, Rocco Savino 2002-11-05
6464998 Composition for the in vivo production of therapeutic products Yves Beuzard, Olivier Danos, Vincent Descamps, Jean-Michel Heard, Philippe Moullier +2 more 2002-10-15
6458529 Assays for promoter operability in central nervous system cells Axel Kahn, Gildas Le Gal La Salle, Jacques Mallet, Marc Peschanski, Jean-Jacques Robert 2002-10-01
6426216 Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter Annick Ballay, Massimo Levredo, Pierre Tiollais 2002-07-30
6420170 Recombinant adenoviruses containing an inducible promoter controlling a gene of viral origin Martine Latta, Edouard Prost, Patrice Yeh, Cecile Orsini, Emmanuelle Vigne 2002-07-16
6410011 Gene therapy for restenosis using an adenoviral vector Didier Branellec, Jean-Francois Dedieu, Patrice Denefle, Laurent Feldman, Philippe Gabriel Steg 2002-06-25
6387670 Method for producing recombinant virus Hélène Leblois-Prehaud, Emmanuelle Vigne, Patrice Yeh 2002-05-14